News | January 23, 2025
Neuland Labs board approves Capex of Rs. 342 Cr
The company plans to fund this Capex through debt and internal accruals and expects the project to be completed by FY27
The company plans to fund this Capex through debt and internal accruals and expects the project to be completed by FY27
Regulatory filings underway for a third indication for darolutamide in prostate cancer, for finerenone in a common form of heart failure, and acoramidis in transthyretin amyloid
Dr. Smith brings 30 years of clinical and translational research experience in obesity, diabetes, and metabolism with over 300 scientific publications
Anthem’s business comprises of CRDMO services and the manufacture and sale of Specialty Ingredients
Jagsonpal Pharmaceuticals has received full consideration of Rs. 41 crore towards the sale of the facility and will now be proceeding with registration formalities
Octreotide is synthetic peptide manufactured by Shilpa Pharma Lifesciences through solid phase synthesis
The GMP inspection assessed mammalian and microbial drug substance manufacturing facility sections
The inspection concluded with the issuance of Form 483 with four observations which are procedural in nature
This is used to treat central diabetes insipidus and bedwetting
Critical resources will help Genvor to grow and scale biological crop protection products and innovative trait technologies
Subscribe To Our Newsletter & Stay Updated
